首页> 外国专利> New bromocriptine is prolactin inhibitor, useful for initiating, without concurrent medication, prolactin increase in male and female depressed patients for normalization of mood, and for treatment of reactive and endogenous depression

New bromocriptine is prolactin inhibitor, useful for initiating, without concurrent medication, prolactin increase in male and female depressed patients for normalization of mood, and for treatment of reactive and endogenous depression

机译：新的溴隐亭是催乳素抑制剂，可用于在不同时用药的情况下启动男性和女性抑郁症患者的催乳激素升高，以使情绪正常化以及治疗反应性和内源性抑郁症

页面导航

摘要
著录项
相似文献

摘要

Bromocriptine initiating, without concurrent medication, prolactin increase in male and female depressed patients for the normalization of mood, in a relapse-free treatment for 30 days, is new. ACTIVITY : Neuroprotective; Antidepressant. MECHANISM OF ACTION : Prolactin inhibitor.

机译：在无复发治疗30天的情况下，启动溴隐亭，而无需同时用药，可使男性和女性抑郁症患者的催乳素增加，从而使情绪恢复正常。活动：具有神经保护作用;抗抑郁药。作用机理：催乳素抑制剂。

著录项

公开/公告号DE102010004986A1

专利类型
公开/公告日2011-07-21

原文格式PDF
申请/专利权人 WAEHNERT VOLKER;
展开▼

申请/专利号DE20101004986
发明设计人 WAEHNERT VOLKER;
展开▼

申请日2010-01-19
分类号A61K31/4985;A61P25/24;A61P5/08;
国家 DE
入库时间 2022-08-21 17:47:28

相似文献

专利
外文文献